Vienna, Austria

Krzysztof Chylinski

USPTO Granted Patents = 62 

 

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 427(Granted Patents)


Inventors with similar research interests:


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
RNA-Directed Target DNA Modification
Transcription Modulation
Conditional CRISPR sgRNA Expression
Genetic Engineering
Gene Editing Techniques
CRISPR Technology
RNA Interference
Molecular Biology
Synthetic Biology
Biotechnology Innovations
Gene Therapy Applications
Nucleic Acid Technologies
62 patents (USPTO):Explore Patents

Title: Profile of Krzysztof Chylinski: Leading Innovator in RNA-Directed Technology

Introduction: Krzysztof Chylinski, based in Vienna, Austria, is a prominent inventor known for his significant contributions to the field of RNA-directed technology. With an impressive portfolio of 62 patents, Chylinski has been at the forefront of innovations that have the potential to revolutionize genetic engineering and molecular biology.

Latest Patents: Among his latest patents, Chylinski has developed methods and compositions for RNA-directed target DNA modification and modulation of transcription. This groundbreaking work includes the provision of a DNA-targeting RNA that incorporates a targeting sequence to achieve site-specific modification of target DNA and associated polypeptides. His innovations encompass methods that involve the use of an enzymatically inactive Cas9 polypeptide, allowing for precise modulation of transcription in target cells. Additionally, Chylinski has contributed to the development of kits and compositions designed to facilitate these techniques, along with genetically modified cells and transgenic non-human multicellular organisms capable of producing Cas9.

Career Highlights: Chylinski's professional journey includes significant roles at esteemed institutions, notably the University of Vienna and the University of California. His work not only showcases his expertise but also highlights his dedication to advancing the field of genetic research through innovative methodologies.

Collaborations: Throughout his career, Chylinski has collaborated with notable scientists such as Jennifer A. Doudna and Martin Jinek. These partnerships have fostered an environment of shared knowledge and have led to advancements in CRISPR technology and gene editing techniques.

Conclusion: Krzysztof Chylinski's innovative contributions to RNA-directed technologies have positioned him as a key figure in modern genetic research. With his extensive patent portfolio and collaborative efforts with leading scientists, he continues to push the boundaries of what is possible in the domain of molecular biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…